Clinical trial

Effect of Safinamide on Parkinson's Disease Related Chronic Pain

NCT03841604

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-09

PhasePHASE4

Study timeline

Study start (actual)2019-04-09Date precision: day

Registry last updated2023-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Idiopathic Parkinson Diseaseunresolved

Interventions

Safinamide MethanesulfonateDRUG

Safinamide methanesulfonate matching placeboOTHER

Sponsors & collaborators

Zambon SpAlead sponsor

Mapped research locations

MadridSpain3 BarcelonaSpain3 MilanItaly3 RomaItaly3 SevilleSpain2 UlmGermany2 BerlinGermany1 ValenciaSpain1 ToulouseFrance1 MarseilleFrance1 StrasbourgFrance1 ViennaAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03841604 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.